Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
News
New antivirals, more screening could slash hepatitis C cases
Publish date:
December 11, 2015
FROM CLINICAL INFECTIOUS DISEASES
References
koakes@frontlinemedcom.com
On Twitter
@karioakes
Pages
« first
1
2
Recommended Reading
Transplant waiting-list registrations dropped after direct acting–antiviral approval
MDedge Family Medicine
Investigational hepatitis B therapy shows activity in proof-of-concept study
MDedge Family Medicine
Elevated liver cancer risk after HCV cure may justify surveillance
MDedge Family Medicine
AASLD: Pilot study shows value of response-guided therapy for HCV GT1b
MDedge Family Medicine
AASLD: HCV cure associated with reduction in all-cause mortality
MDedge Family Medicine
VIDEO: U.S. hepatitis C treatment capacity falls short of need
MDedge Family Medicine
Short-course DAA regimens for HCV provide limited cure rates
MDedge Family Medicine
ARC-520 shows promise in chronic hepatitis B
MDedge Family Medicine
Proportion of HCV patients in U.S. with cirrhosis climbing
MDedge Family Medicine
ELF the most effective mortality predictor for coinfected HIV, HCV patients
MDedge Family Medicine
Gastroenterology
Infectious Diseases
Hepatology
All Specialties
